SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : qtrn(quintiles trans)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jason W. May who wrote (27)8/19/1999 3:57:00 PM
From: Thomas J Pittman  Read Replies (1) of 105
 
All I can say is that I agree with you. It is hard to imagine that qtrn isnt a good long term buy. And yet, the
stock has been really dragging.

I spoke recently (and briefly) with the chief pharma analyst of a major WS firm about this subindustry. He
said it was clearly a growing trend, aligned with the
overall demographic trend, and the only way that the big
pharmas were going to be able to maximize their research
dollars was to make use of the CROs. He then added that
qtrn was the obvious way to play those trends.

how that jives with a stock price at or near 52 week lows, i dont know.

i have a lot of trouble not buying, i can tell you that.
something isnt right though since i DO believe that i am
not smarter than everyone, someone must know something
additional that is holding this back.

J
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext